The AGA has released a living guideline for ulcerative colitis (UC), reshaping treatment protocols as new therapies emerge. Key updates include refined treatment algorithms, disease severity stratification, and guidance on step-up/step-down therapy.
Dr. Adam Gluskin, a gastroenterologist with GI Alliance of Illinois, emphasizes the need for continuous learning as rapid drug approvals outpace clinical workflows and insurance adoption. Staying current is essential as precision medicine and emerging treatments begin to redefine UC care.